Philip W. Connelly focuses on Internal medicine, Endocrinology, Cholesterol, Diabetes mellitus and Lipoprotein. His work in Internal medicine is not limited to one particular discipline; it also encompasses Hyperlipidemia. His Endocrinology research is multidisciplinary, incorporating elements of Soy protein and Gestational diabetes.
His Cholesterol research is multidisciplinary, relying on both Statin, Molecular biology, Blood plasma and Ratón. His studies deal with areas such as Surgery, Carbohydrate and Risk factor as well as Diabetes mellitus. The various areas that Philip W. Connelly examines in his Lipoprotein study include Pathophysiology and Immunology.
His main research concerns Internal medicine, Endocrinology, Diabetes mellitus, Gestational diabetes and Cholesterol. His work deals with themes such as Pregnancy and Type 2 diabetes, which intersect with Internal medicine. His work in the fields of Glucose tolerance test, Apolipoprotein B, Adiponectin and Insulin overlaps with other areas such as Context.
His Diabetes mellitus research focuses on Odds ratio and how it relates to Confidence interval. The concepts of his Gestational diabetes study are interwoven with issues in Insulin sensitivity and Glucose homeostasis. His Cholesterol study incorporates themes from Soy protein and Diet therapy.
Internal medicine, Gestational diabetes, Endocrinology, Type 2 diabetes and Diabetes mellitus are his primary areas of study. Philip W. Connelly combines topics linked to Cardiology with his work on Internal medicine. His study looks at the relationship between Gestational diabetes and topics such as Insulin sensitivity, which overlap with Physiology, Beta-cell Function and Carbohydrate metabolism.
Endocrinology is often connected to Protective factor in his work. His study on Impaired glucose tolerance is often connected to Context as part of broader study in Diabetes mellitus. His research integrates issues of Cholesterol, Lipoprotein, Apolipoprotein B, Obstetrics and C-reactive protein in his study of Pregnancy.
Philip W. Connelly mainly investigates Internal medicine, Gestational diabetes, Gestation, Insulin sensitivity and Endocrinology. Internal medicine is closely attributed to Cardiology in his study. Philip W. Connelly has included themes like Diabetes mellitus and Impaired glucose tolerance in his Gestational diabetes study.
His biological study spans a wide range of topics, including Carbohydrate metabolism and Physiology. His Insulin sensitivity research is multidisciplinary, incorporating perspectives in Beta-cell Function, Gastroenterology, Liver fat, Fatty liver and Glucose homeostasis. Endocrinology is closely attributed to Postpartum period in his research.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A major role for VCAM-1, but not ICAM-1, in early atherosclerosis
Myron I. Cybulsky;Kaeko Iiyama;Hongmei Li;Suning Zhu.
Journal of Clinical Investigation (2001)
Effects of a Dietary Portfolio of Cholesterol-Lowering Foods vs Lovastatin on Serum Lipids and C-Reactive Protein
David J. A. Jenkins;Cyril W. C. Kendall;Augustine Marchie;Dorothea A. Faulkner.
JAMA (2003)
Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins.
Michael I. Mackness;Bharti Mackness;Paul N. Durrington;Philip W. Connelly.
Current Opinion in Lipidology (1996)
Dose Response of Almonds on Coronary Heart Disease Risk Factors: Blood Lipids, Oxidized Low-Density Lipoproteins, Lipoprotein(a), Homocysteine, and Pulmonary Nitric Oxide A Randomized, Controlled, Crossover Trial
David J.A. Jenkins;Cyril W.C. Kendall;Augustine Marchie;Tina L. Parker.
Circulation (2002)
Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women
David J A Jenkins;Cyril W C Kendall;Chung-Ja C Jackson;Philip W Connelly.
The American Journal of Clinical Nutrition (2002)
The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein
Thomas M S Wolever;Alison L Gibbs;Christine Mehling;Jean-Louis Chiasson.
The American Journal of Clinical Nutrition (2008)
C-reactive protein and gestational diabetes: the central role of maternal obesity.
Ravi Retnakaran;Anthony J. G. Hanley;Nuryt Raif;Philip W. Connelly.
The Journal of Clinical Endocrinology and Metabolism (2003)
Effect on Blood Lipids of Very High Intakes of Fiber in Diets Low in Saturated Fat and Cholesterol
David Jenkins;Thomas Wolever;A. Venketeshwer Rao;Robert A. Hegele.
The New England Journal of Medicine (1993)
Influence of Interferon-γ on the Extent and Phenotype of Diet-Induced Atherosclerosis in the LDLR-Deficient Mouse
Chiara Buono;Carolyn E. Come;George Stavrakis;Graham F. Maguire.
Arteriosclerosis, Thrombosis, and Vascular Biology (2003)
Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants
David J A Jenkins;Cyril W C Kendall;Augustine Marchie;Dorothea A Faulkner.
The American Journal of Clinical Nutrition (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Toronto
University of Toronto
University of Toronto
University of Western Ontario
University of Toronto
University of Western Ontario
University of Toronto
University of Toronto
University of Toronto
University of Cambridge
University of Washington
University of Science and Technology of China
Texas A&M University
Oak Ridge National Laboratory
National Tsing Hua University
Australian National University
Leiden University
Simon Fraser University
National Museum of Natural History
Agricultural Research Service
University of Missouri
Plymouth Marine Laboratory
Université Laval
University of Münster
Chinese University of Hong Kong
Columbia University